Anatara Life Sciences (ASX:ANR) back on track for irritable bowel syndrome (IBS) trial recruitment
Anatara Life’s (ANR) 200-patient Gastrointestinal ReProgramming (GaRP) trial had gained momentum, with…
Fri, 01 Nov | Close | Change |
4:54pm | 8,118.8 | 41.2 |
Closed at Mon, 04 Nov 6:21am |
S&P/ASX Sm. Ords. | 3,136.7 | 22.6 | 0.72% |
All Ordinaries | 8,379.7 | 42.4 | 0.50% |
S&P/ASX 100 | 6,816.9 | 33.7 | 0.49% |
MNC | MERINO & CO. LIMITED | 46.5¢ | 75.5% |
BDG | BLACK DRAGON GOLD CORP. | 6.7¢ | 52.3% |
RTG | RTG MINING INC. | 3.6¢ | 38.5% |
ZMI | ZINC OF IRELAND NL | 0.9¢ | 25.0% |
RMX | RED MOUNTAIN MINING LIMITED | 1.0¢ | 23.1% |
ATS | AUSTRALIS OIL & GAS LIMITED | 0.8¢ | 20.0% |